Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quidelortho Corp
(NQ:
QDEL
)
42.25
-1.33 (-3.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quidelortho Corp
< Previous
1
2
3
4
5
6
7
Next >
10 Health Care Stocks Whale Activity In Today's Session
August 08, 2024
Via
Benzinga
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
July 24, 2024
Via
Benzinga
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024
May 08, 2024
QDEL stock results show that QuidelOrtho missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
April 02, 2024
QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay withdrawal, company promises a new multiplex assay for 2024/2025...
Via
Benzinga
Exposures
COVID-19
Product Safety
Analyst Scoreboard: 6 Ratings For QuidelOrtho
March 04, 2024
Via
Benzinga
Why QuidelOrtho Stock Is Crashing Today
February 14, 2024
The in vitro diagnostics company had a lot of bad news in its Q4 update.
Via
The Motley Fool
Recap: QuidelOrtho Q4 Earnings
February 13, 2024
Via
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 02, 2024
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Via
Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Wall Street's Top 10 Stock Calls This Week - Saturday, March 9
March 09, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of March 4-8.
Via
Talk Markets
Earnings Preview For QuidelOrtho
February 12, 2024
Via
Benzinga
Analyst Expectations for QuidelOrtho's Future
November 02, 2023
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 17
February 17, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 12-16, 2024.
Via
Talk Markets
Dow Edges Higher; QuidelOrtho Shares Plummet
February 14, 2024
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
February 14, 2024
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 14, 2024
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list...
Via
Benzinga
QuidelOrtho Analysts Cut Their Forecasts After Downbeat Results
February 14, 2024
QuidelOrtho Corp (NASDAQ: QDEL) posted weaker-than-expected results for its fourth quarter on Tuesday.
Via
Benzinga
Why Is Diagnostic Maker QuidelOrtho Stock Crashing Wednesday?
February 14, 2024
QuidelOrtho's Q4 2023 EPS at $1.17, below consensus $2.05. Sales: $742.6M, missing estimate $796.91M. Respiratory revenue down 49%. William Blair downgrades to Market Perform.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 14, 2024
Via
Benzinga
Crude Oil Moves Lower; Louisiana-Pacific Posts Upbeat Earnings
February 14, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
February 14, 2024
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 14, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news affecting shares on Wednesday morning!
Via
InvestorPlace
US Stocks Priming For Relief Rally After Inflation-Driven Selloff: Strategist Expects To Be Among 'Buyers Of Pullback' Over Next 2-5 Days
February 14, 2024
The lone piece of Main Street catalyst due for the day is a speech by a supposedly "centrist" Fed official.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Airbnb Reports Q4 Results, Joins MGM Resorts, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
February 14, 2024
U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 80 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 13, 2024
Via
Benzinga
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
November 16, 2023
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm.
Via
Benzinga
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst
October 12, 2023
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,
Via
Benzinga
Earnings Scheduled For February 13, 2024
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.